These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34756767)

  • 1. Re-worsening left ventricular ejection fraction after response to cardiac resynchronization therapy.
    Oki T; Ishii S; Takigami Y; Eda Y; Maemura K; Yazaki M; Fujita T; Ikeda Y; Nabeta T; Maekawa E; Koitabashi T; Ako J
    J Cardiol; 2022 Mar; 79(3):358-364. PubMed ID: 34756767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Kutyifa V; Kloppe A; Zareba W; Solomon SD; McNitt S; Polonsky S; Barsheshet A; Merkely B; Lemke B; Nagy VK; Moss AJ; Goldenberg I
    J Am Coll Cardiol; 2013 Mar; 61(9):936-44. PubMed ID: 23449428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy.
    Dreger H; Borges AC; Baumann G; Melzer C
    Cardiovasc Ultrasound; 2010 Sep; 8():35. PubMed ID: 20809960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of left ventricular function under cardiac resynchronization therapy goes along with a reduced incidence of ventricular arrhythmia.
    Eickholt C; Siekiera M; Kirmanoglou K; Rodenbeck A; Heussen N; Schauerte P; Lichtenberg A; Balzer J; Rassaf T; Perings S; Kelm M; Shin DI; Meyer C
    PLoS One; 2012; 7(11):e48926. PubMed ID: 23152822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrically guided versus imaging-guided implant of the left ventricular lead in cardiac resynchronization therapy: a study protocol for a double-blinded randomized controlled clinical trial (ElectroCRT).
    Stephansen C; Sommer A; Kronborg MB; Jensen JM; Bouchelouche K; Nielsen JC
    Trials; 2018 Nov; 19(1):600. PubMed ID: 30382923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of Cardiac Resynchronization Therapy for Heart Failure Due to Dilated Cardiomyopathy in a 61-Year-Old Female "-Super-Responder" with Return of a Reduced Left Ventricular Ejection Fraction to Normal.
    Hoshiba Y; Sugimoto A; Doi S; Sawada T; Tamiya S; Ito D; Iseki H
    Am J Case Rep; 2020 Sep; 21():e926704. PubMed ID: 32986689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    Kanai M; Yagishita D; Shoda M; Ejima K; Hagiwara N
    J Cardiol; 2022 Jan; 79(1):6-14. PubMed ID: 34426046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Frailty Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy.
    Kubala M; Guédon-Moreau L; Anselme F; Klug D; Bertaina G; Traullé S; Buiciuc O; Savouré A; Diouf M; Hermida JS
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1523-1533. PubMed ID: 29759834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.
    Sardu C; Barbieri M; Santamaria M; Giordano V; Sacra C; Paolisso P; Spirito A; Marfella R; Paolisso G; Rizzo MR
    Cardiovasc Diabetol; 2017 Jun; 16(1):75. PubMed ID: 28599667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the lowest value of left ventricular baseline ejection fraction that predicts response to cardiac resynchronization therapy?
    Agacdiken Agir A; Celikyurt U; Sahin T; Yılmaz I; Karauzum K; Bozyel S; Ural D; Vural A
    Med Sci Monit; 2014 Sep; 20():1641-6. PubMed ID: 25218410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
    van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-life data on heart failure before and after implantation of resynchronization and/or defibrillation devices - the Síncrone study.
    Bonhorst D; Guerreiro S; Fonseca C; Cardim N; Macedo F; Adragão P
    Rev Port Cardiol (Engl Ed); 2019 Jan; 38(1):33-41. PubMed ID: 30685295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
    Varma N; Sogaard P; Bax JJ; Abraham WT; Borer JS; Dickstein K; Singh JP; Gras D; Holzmeister J; Brugada J; Ruschitzka F
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29807890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.